| Antiproliferative potency of novel benzofuran-2-carboxamides on tumour cell lines: cell death mechanisms and determination of crystal structure M Hranjec, I Sović, I Ratkaj, G Pavlović, N Ilić, L Valjalo, K Pavelić, ... European journal of medicinal chemistry 59, 111-119, 2013 | 70 | 2013 |
| Smurf2 regulates stability and the autophagic–lysosomal turnover of lamin A and its disease‐associated form progerin AP Borroni, A Emanuelli, PA Shah, N Ilić, L Apel‐Sarid, B Paolini, ... Aging cell 17 (2), e12732, 2018 | 51 | 2018 |
| Challenges for super-resolution localization microscopy and biomolecular fluorescent nano-probing in cancer research M Hausmann, N Ilić, G Pilarczyk, JH Lee, A Logeswaran, A Borroni, ... International journal of molecular sciences 18 (10), 2066, 2017 | 46 | 2017 |
| Could LogP be a principal determinant of biological activity in 18-crown-6 ethers? Synthesis of biologically active adamantane-substituted diaza-crowns F Supek, TŠ Ramljak, M Marjanović, M Buljubašić, G Kragol, N Ilić, ... European journal of medicinal chemistry 46 (8), 3444-3454, 2011 | 42 | 2011 |
| Novel phenyl and pyridyl substituted derivatives of isoindolines: Synthesis, antitumor activity and DNA binding features I Sović, SK Pavelić, E Markova-Car, N Ilić, R Nhili, S Depauw, ... European journal of medicinal chemistry 87, 372-385, 2014 | 26 | 2014 |
| Running for time: circadian rhythms and melanoma EP Markova-Car, D Jurišić, N Ilić, S Kraljević Pavelić Tumor biology 35 (9), 8359-8368, 2014 | 24 | 2014 |
| Synthesis and in vitro antiproliferative evaluation of novel N-alkylated 6-isobutyl-and propyl pyrimidine derivatives TG Kraljević, N Ilić, V Stepanić, L Sappe, J Petranović, SK Pavelić, ... Bioorganic & medicinal chemistry letters 24 (13), 2913-2917, 2014 | 22 | 2014 |
| Novel 2-thienyl-and 2-benzothienyl-substituted 6-(2-imidazolinyl) benzothiazoles: Synthesis; in vitro evaluation of antitumor effects and assessment of mitochondrial toxicity L Racané, M Sedic, N Ilic, M Aleksic, S Kraljevic Pavelic, ... Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2017 | 20 | 2017 |
| Synthesis, antitumor activity and DNA binding features of benzothiazolyl and benzimidazolyl substituted isoindolines I Sović, S Jambon, SK Pavelić, E Markova-Car, N Ilić, S Depauw, ... Bioorganic & medicinal chemistry 26 (8), 1950-1960, 2018 | 19 | 2018 |
| The novel coumarin[3,2-c]thiophene and its hydroxamic acid and ureido derivatives: synthesis and cytostatic activity evaluations K Wittine, I Ratkaj, K Benci, T Suhina, L Mandić, N Ilić, SK Pavelić, ... Medicinal Chemistry Research 25 (4), 728-737, 2016 | 13 | 2016 |
| Design, synthesis, and cytostatic activity of novel pyrazine sorafenib analogs ZR Džolić, I Perković, SK Pavelić, M Sedić, N Ilić, D Schols, B Zorc Medicinal Chemistry Research 25 (12), 2729-2741, 2016 | 11 | 2016 |
| Generation of SMURF2 knockout human cells using the CRISPR/Cas9 system DM Ayyathan, N Ilić, H Gil-Henn, M Blank Analytical biochemistry 531, 56-59, 2017 | 9 | 2017 |
| SMURF2‐mediated ubiquitin signaling plays an essential role in the regulation of PARP1 PARylating activity, molecular interactions, and functions in mammalian cells N Ilić, Y Tao, S Boutros‐Suleiman, VN Kadali, A Emanuelli, ... The FASEB Journal 35 (4), e21436, 2021 | 6 | 2021 |
| Synthesis and biological activity of novel benzimidazolyl and benzothiazolyl substituted isoindolines I Sović, S Jambon, S Kraljević-Pavelić, E Markova-Car, N Ilić, S Depauw, ... 17th TETRAHEDRON SYMPOSIUM-Challenges in Biological, Bioorganic, Organic …, 2016 | | 2016 |
| Sphingosine kinase inhibition sensitizes hepatocellular carcinoma cells to chemotherapy N Ilić, P Grbčić, I Tomljanović, SK Pavelić, M Sedić 11th Central European Oncology Congress, Croatian Society of Oncology’s Best …, 2015 | | 2015 |
| Učinak različitih makrocikličkih spojeva na proliferaciju stanica tumora in vitro N Ilić University of Zagreb. Faculty of Science. Department of Biology., 2009 | | 2009 |
